What is the share price of Abbott India Ltd (ABBOTINDIA) today?
The share price of ABBOTINDIA as on 13th June 2025 is ₹31515. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Abbott India Ltd (ABBOTINDIA) share?
The past returns of Abbott India Ltd (ABBOTINDIA) share are- Past 1 week: -0.39%
- Past 1 month: 4.90%
- Past 3 months: 6.48%
- Past 6 months: 11.55%
- Past 1 year: 14.12%
- Past 3 years: 76.01%
- Past 5 years: 95.83%
What are the peers or stocks similar to Abbott India Ltd (ABBOTINDIA)?
The peers or stocks similar to Abbott India Ltd (ABBOTINDIA) include:What is the dividend yield % of Abbott India Ltd (ABBOTINDIA) share?
The current dividend yield of Abbott India Ltd (ABBOTINDIA) is 1.51.What is the market cap of Abbott India Ltd (ABBOTINDIA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Abbott India Ltd (ABBOTINDIA) is ₹66878.72 Cr as of 13th June 2025.What is the 52 week high and low of Abbott India Ltd (ABBOTINDIA) share?
The 52-week high of Abbott India Ltd (ABBOTINDIA) is ₹32200 and the 52-week low is ₹25325.What is the PE and PB ratio of Abbott India Ltd (ABBOTINDIA) stock?
The P/E (price-to-earnings) ratio of Abbott India Ltd (ABBOTINDIA) is 47.28. The P/B (price-to-book) ratio is 18.08.Which sector does Abbott India Ltd (ABBOTINDIA) belong to?
Abbott India Ltd (ABBOTINDIA) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Abbott India Ltd (ABBOTINDIA) shares?
You can directly buy Abbott India Ltd (ABBOTINDIA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Abbott India Ltd
ABBOTINDIA Share Price
31,515.000.19% (-60.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
ABBOTINDIA Performance & Key Metrics
ABBOTINDIA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 47.28 | 18.08 | 1.51% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.21 | 6.66 | 0.83% |
88%
Analysts have suggested that investors can buy this stock
from 8 analysts
Price Upside
Earnings Growth
Rev. Growth
ABBOTINDIA Company Profile
Abbott India is a healthcare company engaged in pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
SUNPHARMA
PE Ratio
37.00
37.00
1Y Return
11.72%
11.72%
Buy Reco %
87.88
87.88
CIPLA
PE Ratio
23.03
23.03
1Y Return
2.38%
2.38%
Buy Reco %
74.19
74.19
DRREDDY
PE Ratio
20.02
20.02
1Y Return
11.76%
11.76%
Buy Reco %
56.67
56.67
TORNTPHARM
PE Ratio
57.53
57.53
1Y Return
13.13%
13.13%
Buy Reco %
72.00
72.00
MANKIND
PE Ratio
49.29
49.29
1Y Return
6.30%
6.30%
Buy Reco %
81.25
81.25
ABBOTINDIA Forecast
ABBOTINDIA Forecasts
Price
Revenue
Earnings
ABBOTINDIA Share Price Forecast
ABBOTINDIA Share Price Forecast
2025
Current
₹31,515.00
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹31,515.00
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
ABBOTINDIA Company Revenue Forecast
ABBOTINDIA Company Revenue Forecast
2025
Current
₹6.68
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹6.68
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
ABBOTINDIA Stock EPS (Earnings Per Share) Forecast
ABBOTINDIA Stock EPS (Earnings Per Share) Forecast
2025
Current
₹665.62
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹665.62
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
ABBOTINDIA
ABBOTINDIA
Income
Balance Sheet
Cash Flow
Annual Normal View
ABBOTINDIA Income Statement
ABBOTINDIA Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,960.20 | 3,415.49 | 3,791.89 | 4,207.53 | 4,390.92 | 5,015.73 | 5,533.23 | 6,123.53 | 6,684.73 | 6,684.73 | ||||||||||
Raw Materials | 1,813.51 | 2,006.94 | 2,090.78 | 2,254.39 | 2,494.92 | 2,679.49 | 2,908.97 | 3,212.88 | 4,714.55 | 4,714.55 | ||||||||||
| Power & Fuel Cost | 7.74 | 10.26 | 12.61 | 13.73 | 12.74 | 14.98 | 17.15 | 16.63 | ||||||||||||
| Employee Cost | 345.27 | 393.69 | 435.58 | 476.11 | 492.65 | 579.46 | 563.59 | 576.58 | ||||||||||||
| Selling & Administrative Expenses | 353.66 | 365.41 | 432.83 | 400.27 | 366.98 | 459.18 | 467.74 | 429.89 | ||||||||||||
| Operating & Other expenses | -14.93 | -2.30 | 102.07 | 192.19 | 21.27 | 117.69 | 216.00 | 186.18 | ||||||||||||
EBITDA | 454.95 | 641.49 | 718.02 | 870.84 | 1,002.36 | 1,164.93 | 1,359.78 | 1,701.37 | 1,970.18 | 1,970.18 | ||||||||||
| Depreciation/Amortization | 16.43 | 16.19 | 16.92 | 59.61 | 58.13 | 66.10 | 69.97 | 71.17 | 71.80 | 71.80 | ||||||||||
| PBIT | 438.52 | 625.30 | 701.10 | 811.23 | 944.23 | 1,098.83 | 1,289.81 | 1,630.20 | 1,898.38 | 1,898.38 | ||||||||||
| Interest & Other Items | 2.04 | 3.82 | 2.25 | 8.53 | 18.28 | 19.10 | 15.99 | 12.45 | 11.43 | 11.43 | ||||||||||
| PBT | 436.48 | 621.48 | 698.85 | 802.70 | 925.95 | 1,079.73 | 1,273.82 | 1,617.75 | 1,886.95 | 1,886.95 | ||||||||||
| Taxes & Other Items | 159.84 | 220.26 | 248.52 | 209.77 | 235.26 | 281.03 | 324.41 | 416.53 | 472.51 | 472.51 | ||||||||||
| Net Income | 276.64 | 401.22 | 450.33 | 592.93 | 690.69 | 798.70 | 949.41 | 1,201.22 | 1,414.44 | 1,414.44 | ||||||||||
| EPS | 130.19 | 188.82 | 211.93 | 279.04 | 325.04 | 375.87 | 446.80 | 565.30 | 665.62 | 665.64 | ||||||||||
| DPS | 40.00 | 55.00 | 65.00 | 250.00 | 275.00 | 275.00 | 325.00 | 410.00 | 475.00 | 410.00 | ||||||||||
| Payout ratio | 0.31 | 0.29 | 0.31 | 0.90 | 0.85 | 0.73 | 0.73 | 0.73 | 0.71 | 0.62 |
ABBOTINDIA Company Updates
ABBOTINDIA Stock Peers
ABBOTINDIA Past Performance & Peer Comparison
ABBOTINDIA Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Abbott India Ltd | 47.28 | 18.08 | 1.51% |
| Sun Pharmaceutical Industries Ltd | 37.00 | 6.03 | 0.95% |
| Cipla Ltd | 23.03 | 4.53 | 1.06% |
| Dr Reddy's Laboratories Ltd | 20.02 | 4.01 | 0.59% |
ABBOTINDIA Stock Price Comparison
Compare ABBOTINDIA with any stock or ETFCompare ABBOTINDIA with any stock or ETF
ABBOTINDIA
ABBOTINDIA Holdings
ABBOTINDIA Shareholdings
ABBOTINDIA Promoter Holdings Trend
ABBOTINDIA Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ABBOTINDIA Institutional Holdings Trend
ABBOTINDIA Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ABBOTINDIA Shareholding Pattern
ABBOTINDIA Shareholding Pattern
ABBOTINDIA Shareholding History
ABBOTINDIA Shareholding History
Foreign Institutions
Mutual Funds Invested in ABBOTINDIA
Mutual Funds Invested in ABBOTINDIA
Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Abbott India Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 1.2517% | Percentage of the fund’s portfolio invested in the stock 2.67% | Change in the portfolio weight of the stock over the last 3 months -0.38% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 9/88 (-3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.7561% | Percentage of the fund’s portfolio invested in the stock 1.66% | Change in the portfolio weight of the stock over the last 3 months -0.26% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 13/106 (-5) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.6647% | Percentage of the fund’s portfolio invested in the stock 1.77% | Change in the portfolio weight of the stock over the last 3 months -0.40% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 14/119 (-3) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ABBOTINDIA stock
smallcases containing ABBOTINDIA stock
Looks like this stock is not in any smallcase yet.
ABBOTINDIA Events
ABBOTINDIA Events
ABBOTINDIA Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ABBOTINDIA has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 1.51%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹15.09 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ABBOTINDIA Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ABBOTINDIA has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 1.51%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹15.09 every year
ABBOTINDIA Upcoming Dividends
ABBOTINDIA Upcoming Dividends
Cash Dividend
Ex DateEx DateJul 25, 2025
Final
Final | Div/Share: ₹475.00
Dividend/Share
₹475.00
Ex DateEx Date
Jul 25, 2025
ABBOTINDIA Past Dividends
ABBOTINDIA Past Dividends
Cash Dividend
Ex DateEx DateJul 19, 2024
Final
Final | Div/Share: ₹410.00
Dividend/Share
₹410.00
Ex DateEx Date
Jul 19, 2024
Cash Dividend
Ex DateEx DateJul 21, 2023
Final
Final | Div/Share: ₹180.00
Dividend/Share
₹180.00
Ex DateEx Date
Jul 21, 2023
Cash Dividend
Ex DateEx DateJul 21, 2023
Special
Special | Div/Share: ₹145.00
Dividend/Share
₹145.00
Ex DateEx Date
Jul 21, 2023
Cash Dividend
Ex DateEx DateAug 2, 2022
Final
Final | Div/Share: ₹145.00
Dividend/Share
₹145.00
Ex DateEx Date
Aug 2, 2022
Cash Dividend
Ex DateEx DateAug 2, 2022
Special
Special | Div/Share: ₹130.00
Dividend/Share
₹130.00
Ex DateEx Date
Aug 2, 2022
ABBOTINDIA Stock News & Opinions
ABBOTINDIA Stock News & Opinions
Articles & Videos
Spotlight
Abbott India Ltd gains for fifth session
Abbott India Ltd gained for a fifth straight session today. The stock is quoting at Rs 31185, up 0.16% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.24% on the day, quoting at 24600.6. The Sensex is at 80971.74, up 0.29%. Abbott India Ltd has gained around 1.5% in last one month. Meanwhile, Nifty Pharma index of which Abbott India Ltd is a constituent, has gained around 1.86% in last one month and is currently quoting at 21354.2, up 0.08% on the day. The volume in the stock stood at 3824 shares today, compared to the daily average of 9658 shares in last one month.The PE of the stock is 46.66 based on TTM earnings ending March 25.Powered by Capital Market - Live
1 week agoCapital Market - Live
Spotlight
Abbott India Ltd up for five straight sessions
Abbott India Ltd rose for a fifth straight session today. The stock is quoting at Rs 31190, up 1.12% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.39% on the day, quoting at 24780.3. The Sensex is at 81439.19, up 0.31%. Abbott India Ltd has added around 0.56% in last one month. Meanwhile, Nifty Pharma index of which Abbott India Ltd is a constituent, has added around 1.38% in last one month and is currently quoting at 21456.15, up 1.3% on the day. The volume in the stock stood at 8113 shares today, compared to the daily average of 8871 shares in last one month.The PE of the stock is 46.26 based on TTM earnings ending March 25.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Spotlight
Abbott India rises after Q4 PAT jumps 28% YoY to Rs 367 cr; declares dividend of Rs 475 /sh
Profit before tax (PBT) stood at Rs 482.71 crore in Q4 FY25, up 23.9% YoY. Total expenses increased 6% to Rs 1,197.90 crore in Q4 FY25 as against Rs 1,130.10 crore posted in same quarter last year. Cost of material consumed stood at Rs 186.68 crore (up 15.38% YoY), employee benefit expense was at Rs 144.40 crore (down 0.58% YoY) and finance cost was at Rs 3.92 crore (up 39.5% YoY) during the period under review. On full year basis, the company's standalone net profit jumped 17.8% to Rs 1,414.44 crore on a 9.6% rise in revenue from operations to Rs 6,409.15 crore in FY25 over FY24. Meanwhile, the company's board recommended payment of final dividend of Rs 475 per equity share of Rs 10 each for FY25, subject to approval of shareholders at the ensuing Eighty-first annual general meeting of the company scheduled to be held on Wednesday, August 13, 2025. The company has fixed the record date as Friday, 25 July 2025. The aforesaid final dividend, if approved by the members, will be paid on or after Monday, August 18, 2025. Abbott India is a subsidiary of Abbott Laboratories, headquartered in Mumbai. The company provides products and solutions across various therapeutic areas including gastroenterology, women's health, metabolics, central nervous system, vaccines and multi-specialty.Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Corporate
Board of Abbott India recommends final dividend
Abbott India announced that the Board of Directors of the Company at its meeting held on 15 May 2025, inter alia, have recommended the final dividend of Rs 475 per equity Share (i.e. 4750%) , subject to the approval of the shareholders.Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Corporate
Abbott India AGM scheduled
Abbott India announced that the 81th Annual General Meeting(AGM) of the company will be held on 13 August 2025.Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Earnings
Abbott India standalone net profit rises 27.86% in the March 2025 quarter
Net profit of Abbott India rose 27.86% to Rs 367.04 crore in the quarter ended March 2025 as against Rs 287.06 crore during the previous quarter ended March 2024. Sales rose 11.54% to Rs 1604.59 crore in the quarter ended March 2025 as against Rs 1438.63 crore during the previous quarter ended March 2024. For the full year,net profit rose 17.75% to Rs 1414.44 crore in the year ended March 2025 as against Rs 1201.22 crore during the previous year ended March 2024. Sales rose 9.58% to Rs 6409.15 crore in the year ended March 2025 as against Rs 5848.91 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales1604.591438.63 12 6409.155848.91 10 OPM %26.7122.91 -26.4424.84 - PBDT500.64407.87 23 1958.751688.92 16 PBT482.71389.68 24 1886.951617.75 17 NP367.04287.06 28 1414.441201.22 18 Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Corporate
Abbott India to conduct board meeting
Abbott India will hold a meeting of the Board of Directors of the Company on 15 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Abbott India announces resignation of senior management personnel
Abbott India announced the resignation of Namita Shah - Associate Director - New Product Introduction and Therapy Area Strategy of the Company, effective close of business hours of 15 April 2025, to pursue opportunities outside the Company. Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Abbott India appoints senior management personnel
Abbott India has appointed Anushree Kunhambu - Associate Director - New Product Introduction and Therapy Area Strategy effective 01 August 2025. She will be part of the Senior Management team of the Company. Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Abbott India announces change in senior management
Abbott India announced that Namita Shah - Associate Director - New Product Introduction and Therapy Area Strategy, has tendered her resignation from employment of the Company with effect from the close of business hours of 15 April 2025, to pursue opportunities outside the Company. Pursuant to her resignation, she will also cease to be the Senior Management Personnel of the Company effective the said date. Powered by Capital Market - Live
3 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 10.06%, vs industry avg of 9.02%
Over the last 5 years, market share decreased from 1.73% to 1.61%
Over the last 5 years, net income has grown at a yearly rate of 21.68%, vs industry avg of 15.29%